Breast Cancer News (116 articles)

New study provides evidence that absence of the NEDD9 protein limits breast cancer and that NEDD9 could serve as an indicator for aggressive forms of the diseasePHILADELPHIA (October 2, 2009) – Researchers at Fox Chase Cancer Center have demonstrated that a protein called NEDD9 may be...

Published on 2 October 2009, 11:40

Categories: NEDD9 Proteins Breast Cancer

Preliminary results require further analysis and interpretation. Berlin, September 30, 2009 – Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. today announced results from a randomized, placebo-controlled Phase II trial sponsored by Northwestern University. The study, which evaluated...

Published on 30 September 2009, 03:45

Categories: Nexavar Sorafenib Breast Cancer Paclitaxel Chemotherapeutic agent

The drug vorinostat is able to cross the blood-brain barrier and reduce the development of large metastatic tumors in mice brains by 62 percent when compared to mice that did not receive the drug, according to a new study. In humans, the drug has been...

Published on 29 September 2009, 13:00

Categories: Brain Brain Metastases Breast Cancer Drugs Metastatic tumors Vorinostat

Phase II Study in Advanced Breast Cancer:First presentation of results at joint ECCO-ESMO congress in Berlin, Germany (Abstract # 3LBA)Berlin, September 23, 2009 – Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. today announced the full results from their first collaborative...

Published on 23 September 2009, 07:13

Categories: Breast Cancer Capecitabine Nexavar Sorafenib tablets

Researchers find that reproductive differences are not responsible for the lower risk of breast cancer in blind women.Boston, MA - Researchers at Brigham and Women's Hospital (BWH) have found that totally blind women have more than a 50 percent reduction in breast cancer compared to visually...

Published on 18 September 2009, 12:13

Categories: Blindness Breast Cancer Vision Light perception

University of Essex researchers have made a significant breakthrough in the study of breast cancer development which could lead to new treatments for the disease.Led by Dr Elena Klenova of the Department of Biological Sciences, the team has seen its findings make headline news in the new issue of...

Published on 15 September 2009, 06:55

Categories: Breast Cancer CTCF Proteins

SEATTLE – Sept. 8, 2009 – It is well known that survivors of breast cancer have a much higher risk of developing a second breast cancer than women in the general population have of developing a first breast cancer. However, little is known about what lifestyle factors...

Published on 8 September 2009, 04:33

Categories: Alcohol Breast Cancer Lifestyle Factors Obesity Second breast cancer Smoking

Study finds a more than four-fold increased risk of ER negative second cancers.SEATTLE—While long-term tamoxifen use among breast cancer survivors decreases their risk of developing the most common, less aggressive type of second breast cancer, such use is associated with a more than...

Published on 25 August 2009, 18:01

Categories: Breast Cancer Drugs Hormonal Therapy Tamoxifen

Women with breast cancer and depression are at higher risk of cancer recurrence and early death than breast cancer patients without depression, recent research shows. Now, Stanford University School of Medicine scientists have found evidence that the reason could be the psychiatric...

Published on 24 August 2009, 11:16

Categories: Immune System Breast Cancer Depression Stress

. Data validate Femara alone for five years following hormone-receptor positive breast cancer surgery as an optimal first treatment vs. tamoxifen in postmenopausal women . Results show long-term superiority of Femara in improving disease-free survival (P=0.03) and reducing risk of distant...

Published on 24 August 2009, 05:12

Categories: Femara Drugs Tamoxifen Letrozole Breast Cancer Postmenopausal Women Postmenopause

When estrogen-lowering drugs no longer control metastatic breast cancer, the opposite strategy might work. Raising estrogen levels benefited 30 percent of women whose metastatic breast cancer no longer responded to standard anti-estrogen treatment, according to research conducted at Washington...

Published on 19 August 2009, 10:58

Categories: Breast Cancer Estrogen Estrogen therapy Metastatic breast cancer

Basel, 18 August 2009 - RIBBON-2: The first phase III study to show progression-free survival benefit of Avastin as second-line treatment for advanced breast cancerRoche (SIX: RO, ROG; OTCQX: RHHBY) announced today that a Phase III study of Avastin (bevacizumab) in combination with a range of...

Published on 18 August 2009, 03:42

Categories: Avastin Bevacizumab Breast Cancer Chemotherapy HER2 negative breast cancer RIBBON-2 study

Researchers use novel stem-cell method to discover chemical with potency against breast tumors in mice. A multi-institutional team of Boston-area researchers has discovered a chemical that works in mice to kill the rare but aggressive cells within breast cancers that have the ability...

Published on 14 August 2009, 12:49

Categories: Stem cells Chemicals Breast Cancer Cancer Stem Cells

Fairfax, Va. – Drinking wine while undergoing radiation treatment for breast carcinoma may reduce the incidence of skin toxicity in breast cancer patients, according to a study in the August issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of...

Published on 14 August 2009, 12:40

Categories: Wine Oncology Breast Cancer Radiation Skin toxicity Breast carcinoma

ANN ARBOR, Mich. -- A new review says using magnetic resonance imaging (MRI) before surgery to assess the extent of early breast cancer has not been shown to improve surgical planning, reduce follow-up surgery, or reduce the risk of local recurrences.The review, appearing early online in CA: A...

Published on 13 August 2009, 11:00

Categories: Magnetic resonance imaging MRI Breast Cancer

Findings Pave Way for New Recommendations to Nation’s 2.4 Million Breast Cancer Survivors.PHILADELPHIA –  Breast cancer survivors who lift weights are less likely than their non-weightlifting peers to experience worsening symptoms of lymphedema, the arm- and hand-swelling...

Published on 13 August 2009, 08:14

Categories: Lymphedema Breast Cancer Surgery Breast Cancer Lifting Weights Lymphedema Symptoms

Physicians will be able to offer more patients Avastin-based treatment options.More patients with advanced breast cancer could benefit from Avastin as a result of a broader label allowing Avastin to be combined with both docetaxel or paclitaxel chemotherapy, Roche announced today. In March 2007,...

Published on 29 July 2009, 10:18

Categories: Avastin Breast Cancer Chemotherapy Docetaxel Paclitaxel

Statistically Significant Results Reported from a Phase II Study Combining Two Oral Cancer Therapies. Berlin, July 22, 2009 – Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. today announced that their first cooperative group-sponsored randomized Phase II trial in advanced metastatic...

Published on 22 July 2009, 09:56

Categories: Nexavar Sorafenib Capecitabine Breast Cancer

Emory researchers have developed tools for improving the diagnosis of breast cancer by attaching onto iron oxide "nanoparticles" a molecule that binds specifically to breast cancer cells.The iron makes the particles clearly visible under magnetic resonance imaging (MRI), and thus could...

Published on 21 July 2009, 11:40

Categories: Breast Cancer MRI Nanoparticles

COLUMBIA, Mo. - Previous studies have found that postmenopausal women who have taken a combined estrogen and progestin hormone replacement therapy have increased their risk of developing progestin-accelerated breast tumors. Now, University of Missouri researchers have found that curcumin, a...

Published on 13 July 2009, 13:06

Categories: Asian Spice Breast Cancer Cancer Curcumin Hormone replacement therapy Menopause Spice